Sen. Eric Schmitt

Maddy summaryS 2210, the Iran Sanctions Relief Review Act, requires the President to submit a detailed report to Congress before terminating, waiving, or significantly altering U.S. sanctions on Iran. Congress then has 30 days (or 60 days during summer months) to review the proposal through committee hearings and decide whether to approve or disapprove it via joint resolution. During this review period, the President cannot implement the sanction change without Congressional approval. The bill directly affects the executive branch's ability to modify Iran sanctions policy and gives Congress formal oversight authority over major foreign policy shifts related to Iran.

Maddy summaryThis bill changes a date reference in existing law regarding the CDC Director's appointment timeline. It amends Section 2101(b) of the 2022 pandemic preparedness law by replacing "January 20, 2025" with "the date of enactment of the CDC Accountability Act of 2023." This procedural adjustment directly affects the timing for appointing the CDC Director under the referenced law. The bill does not create new policies or alter substantive responsibilities.

Maddy summarySRES 254 is a 2023 Senate resolution that symbolically condemns antisemitism and endorses the International Holocaust Remembrance Alliance's (IHRA) widely adopted working definition of antisemitism. It urges U.S. federal, state, and local governments, along with academic institutions and civil society groups, to use the IHRA definition as a standard tool for identifying and addressing antisemitism. The resolution specifically highlights examples of antisemitism, such as Holocaust denial, conspiracy theories about Jewish control, and blaming Jewish communities for Israel's actions. As a non-binding resolution, it does not create new laws or directly affect any group but formally supports the IHRA definition's global use in combating antisemitism.

Maddy summaryThis resolution (SRES 256) is a symbolic Senate recognition of Father's Day and the documented benefits of father engagement in maternal and child health. It cites research showing that when fathers are involved in prenatal care, they help mothers access early care, reduce risks of perinatal mental health challenges, improve birth outcomes, and support healthy child development. The resolution does not create new laws, allocate funds, or impose requirements - it simply acknowledges these findings and encourages healthcare systems to better involve fathers. It is a non-binding acknowledgment of existing research, not a policy change affecting any specific group.

Maddy summaryThe CONNECT for Health Act of 2023 expands Medicare telehealth coverage by removing geographic restrictions, allowing services to be provided from home and other locations, and expanding who can offer telehealth services. The bill repeals the six-month in-person visit requirement for telemental health and allows telehealth use in hospice care recertification. It also includes program integrity measures to address inappropriate billing patterns and requires posting of telehealth service data to improve transparency. This legislation directly affects Medicare beneficiaries, healthcare providers, and telehealth technology vendors by making telehealth more accessible, particularly for rural and underserved populations, those with mobility challenges, and individuals in areas with healthcare workforce shortages.

Maddy summaryThis bill prohibits state and local governments from imposing additional production standards on agricultural products grown in another state but sold in interstate commerce, unless those standards already apply under federal law or the state where production occurs. It directly affects farmers, distributors, and businesses operating across state lines by preventing states from creating new barriers to interstate agricultural trade. Key provisions include creating a federal legal right for affected parties to challenge such state regulations in court, with automatic preliminary injunctions to halt enforcement pending resolution. The law also sets a 10-year limit for filing lawsuits and specifies where cases can be heard.

This resolution celebrates the 246th anniversary of the creation of the U.S. flag, recognizes that the Pledge of Allegiance has been a valuable part of life for the people of the United States for generations, and defends the constitutionality of the pledge.

Maddy summaryThis joint resolution (SJRES 31) seeks to block an Environmental Protection Agency (EPA) rule implementing the "Federal Good Neighbor Plan" for ozone air quality standards established under the 2015 National Ambient Air Quality Standards. If approved, it would nullify the EPA rule (published June 5, 2023) that would have required certain states to address ozone pollution crossing state borders. The resolution uses a specific congressional disapproval process under Title 5 of the U.S. Code to prevent the rule from taking effect. This would directly affect states and industries subject to the ozone pollution regulations outlined in the EPA's submitted rule.

Maddy summaryThe Stop TSP ESG Act (S 1891) requires the Thrift Savings Fund (TSP), which manages retirement accounts for federal employees, to delegate voting rights on securities to a qualified professional asset manager instead of exercising them directly. This change would directly affect how the TSP manages its investment portfolio and votes on corporate matters, shifting decision-making to an external manager. The bill's title indicates it aims to address concerns about the TSP's use of Environmental, Social, and Governance (ESG) factors in investment decisions, though the bill text does not explicitly mention ESG. The amendment targets Section 8438(f) of title 5, U.S. Code, which governs TSP operations.

Maddy summaryS 1906, the Promising Pathway Act, creates a faster FDA approval pathway for new drugs treating serious or life-threatening conditions, allowing provisional approval within 90 days of application. It requires drug sponsors to establish patient registries tracking usage and outcomes (with 90% participation minimum), mandates insurers to cover these drugs identically to fully approved drugs, and sets 2-year provisional approval periods renewable up to three times (max 8 years total). The bill includes safety monitoring, with withdrawal if serious side effects outweigh benefits or if full approval isn’t sought within 180 days. This directly affects drug manufacturers, patients with serious conditions, and health insurers by altering approval timelines, coverage rules, and post-approval monitoring.